About the Study

This study is testing the safety and effectiveness of an investigational medication for qualified individuals.

Am I Eligible?

You may be eligible to participate if you are 18 years or older and have been diagnosed with liver cancer.

Study Locations

Find a participating site location near you and take a questionnaire to determine if you may qualify.

Now Seeking Patients

See if you qualify

  • required fields *

testing the effectiveness

About The Study

This study is testing the safety and effectiveness of an investigational medication. Investigational means that this medication has not yet been approved by the US FDA as safe or effective for any use. Qualified individuals may receive study medication during the study unless they experience any side effects requiring treatment discontinuation, with additional quarterly follow-ups as needed.

About The Company

BeiGene is a commercial-stage BioTech company focused on developing and commercializing innovative molecularly-targeted and immune-oncology drugs for the treatment of cancer.

Will I Benefit From Participating In This Study?

The study drug is an investigational product and you may or may not develop a benefit from the study drug. By participating in the Liver Cancer Study, you may:

  • Gain access to specific study-related care and study medication
  • Take an active role in your own healthcare
  • Contribute to medical research and helping to shape the future of medicine

a global health problem

What Is Liver Cancer?

Hepatocellular carcinoma (HCC) is a major global health problem, accounting for 85-90% of all reported cases of liver cancer. According to the World Health Organization, liver cancer was the sixth most common type of cancer in 2012, with 782,000 new cases worldwide. Liver cancer begins in the cells of your liver and most people don’t experience signs or symptoms in the early stages.

Symptoms may include:

  • Weight loss
  • Loss of appetite
  • Upper abdominal pain
  • Nausea and vomiting
  • General weaknesses and fatigue
  • Abdominal swelling
  • Yellow discoloration of your skin and the whites of your eyes
  • White chalky stools

for You Or A Loved One

Am I Eligible?

You Or A Loved One May Qualify If You:

  • Are diagnosed with Liver Cancer (Hepatocellular carcinoma)
  • Are 18 years or older
  • Have not received systematic treatment for liver cancer
  • Are not currently experiencing any health problems as a result of previous cancer treatments (except for hair loss)
  • Do not have liver cancer that has spread to the central nervous system, spinal cord or brain
  • Do not have problems with brain function due to liver cancer known as hepatic encephalopathy

There are additional study requirements to participate. A study representative will discuss them with you.

Got Questions?

FREQUENTLY ASKED QUESTIONS

What is a clinical research study?

A clinical research study tests the safety and effectiveness of a new medicine or treatment in a population of volunteers. All new drug products go through the clinical trial process, therefore, participants like you play a very important role in advancing medicine for present and future generations.

What is an investigational medication?

An investigational medication has been tested in the laboratory and the U.S. Food and Drug Administration (FDA) is allowing it to be tested in people. It is not approved as safe or effective by the FDA and thus is not approved for sale by the FDA or other government agencies. A clinical trial tests how well an investigational medication works and whether it is safe to use for a specific disease or disorder.

How does a clinical trial evaluating an investigational medication work?

A clinical trial has a structured set of clinic visits, tests, and drug dosing schedules the patient must follow. Information about how you feel and how you are reacting to the study treatment is collected.

How are my rights and safety protected as a patient during a clinical trial?

Protecting the health and safety of people who take part in clinical trials is the highest priority for clinical researchers throughout the entire study process. All clinical trials follow strict federal guidelines on how volunteers must be treated. All aspects of the study will be explained to you, and you will have the opportunity to ask questions.

Can I leave the clinical trial before it ends?

You have the right to leave a clinical trial at any time, for any reason. If you decide to leave a trial, talk to your doctor first. You will want to know how leaving the trial might affect your health and what other treatment options may be available.

How can I learn more about the investigational medication and this study?

More information on this clinical trial can be found on clinicaltrials.gov Identifier: NCT03412773.

Where We Are

Study Locations

All current study locations are listed below and more may be added at any time. If you are interested in participating in the Liver Cancer study, complete the form to speak with a study representative regarding your eligibility and available study locations.

Dr. Charles Bane

Precision Cancer Research/Dayton Physicians Network – Treatment
3120 Governors Place Blvd
Kettering, OH 45409

Dr. Subramanya Rao

Healthcare Research Network III, LLC
17333 South La Grange Road
Tinley Park, IL

Dr. Dan Costin

White Plains Hospital Center for Cancer Care
2 Longview Ave.
White Plains, NY 10601

Dr. Tarek Hassanein

Southern California Research Center
131 Orange Avenue Suite 101
Coronado, CA 92118

Dr. Sukeshi Arora

Mays Cancer Center – Oncology
7979 Wurzbach Road Suite Z414
San Antonio, TX 78229

Dr. David Park

St. Jude Heritage Healthcare
2151 N. Harbor Blvd. Suite 2200
Fullerton, CA 92835

Dr. David Park

Monter Cancer Center
450 Lakeville Rd.
Lake Success, NY 11042

Help spread awareness of the Liver Cancer study by sharing with others!